Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Hufsky, FranziskaLamkiewicz, Kevin
Almeida, Alexandre
Aouacheria, Abdel
Arighi, Cecilia
Bateman, Alex
Baumbach, Jan
Beerenwinkel, Niko
Brandt, Christian
Cacciabue, Marco
Chuguransky, Sara
Drechsel, Oliver
Finn, Robert D
Fritz, Adrian
Fuchs, Stephan
Hattab, Georges
Hauschild, Anne-Christin
Heider, Dominik
Hoffmann, Marie
Hölzer, Martin
Hoops, Stefan
Kaderali, Lars
Kalvari, Ioanna
von Kleist, Max
Kmiecinski, Renó
Kühnert, Denise
Lasso, Gorka
Libin, Pieter
List, Markus
Löchel, Hannah F
Martin, Maria J
Martin, Roman
Matschinske, Julian
McHardy, Alice C
Mendes, Pedro
Mistry, Jaina
Navratil, Vincent
Nawrocki, Eric P
O'Toole, Áine Niamh
Ontiveros-Palacios, Nancy
Petrov, Anton I
Rangel-Pineros, Guillermo
Redaschi, Nicole
Reimering, Susanne
Reinert, Knut
Reyes, Alejandro
Richardson, Lorna
Robertson, David L
Sadegh, Sepideh
Singer, Joshua B
Theys, Kristof
Upton, Chris
Welzel, Marius
Williams, Lowri
Marz, Manja
Issue Date
2020-11-04
Metadata
Show full item recordAbstract
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformatics tools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection, understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to get insight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for the routine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemic and evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets and development of therapeutic strategies. For each tool, we briefly describe its use case and how it advances research specifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public code repositories.Citation
Brief Bioinform. 2020 Nov 4:bbaa232. doi: 10.1093/bib/bbaa232. Epub ahead of print.Affiliation
BRICS, Braunschweiger Zentrum für Systembiologie, Rebenring 56,38106 Braunschweig, Germany.Publisher
Oxford AcademicJournal
Briefings in bioinformaticsPubMed ID
33147627Type
ArticleLanguage
enEISSN
1477-4054ae974a485f413a2113503eed53cd6c53
10.1093/bib/bbaa232
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
- Authors: Chen AT, Altschuler K, Zhan SH, Chan YA, Deverman BE
- Issue date: 2021 Feb 23
- Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.
- Authors: Ma L, Li H, Lan J, Hao X, Liu H, Wang X, Huang Y
- Issue date: 2021 Dec
- Bioinformatics resources for SARS-CoV-2 discovery and surveillance.
- Authors: Hu T, Li J, Zhou H, Li C, Holmes EC, Shi W
- Issue date: 2021 Mar 22
- Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
- Authors: Sarkar JP, Saha I, Seal A, Maity D, Maulik U
- Issue date: 2021 Mar
- Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.
- Authors: Ahsan MA, Liu Y, Feng C, Zhou Y, Ma G, Bai Y, Chen M
- Issue date: 2021 Mar 22